3658 results for «247»

Filter By

3658 results

PCR London Valves 2024 Welcome Ceremony: a global milestone in heart valve care

24 Nov 2024 – From PCR London Valves 2024

Discover the incredible journey of PCR London Valves, from its origins in 2009 to becoming the premier global event in heart valve care. What started as a small gathering focused on aortic valve therapies has grown into a landmark event, bringing together nearly 4,000 professionals annually...

PCR London Valves 2024 Welcome Ceremony: a global milestone in heart valve care

TAVI for pure aortic regurgitation - LIVE case

25 Nov 2024 – From PCR London Valves 2024

Watch a LIVE case followed by a recorded case on aortic regurgitation:

  • An 86-year-old male with a history of stroke and prostate cancer presenting acute heart failure due to severe pure aortic regurgitation and LV dysfunction (EF 39%). A 27 mm JenaValve Trilogy prosthesis was implanted without...
TAVI for pure aortic regurgitation

Voices of innovation: perspectives from the stakeholders

25 Nov 2024 – From PCR London Valves 2024

Curious about how innovation becomes impact? This video is a must-watch! Discover now what drives medical breakthroughs from concept to reality and explore the perspectives of those shaping the future of healthcare.

You’ll gain insights into the challenges innovators face at every stage—breakthrough ideas, market regulation, and...

Voices of innovation: perspectives from the stakeholders

Breaking barriers in tricuspid valve repair

25 Nov 2024 – From PCR London Valves 2024

What’s driving the future of transcatheter tricuspid valve repair (TTVR)? Dive into the latest breakthroughs with this video!

Gain insights into real-world outcomes from TTVR registries, uncover key findings from the TriCLASP study, explore how TriClip TEER reshapes the right heart, learn how pulmonary hypertension influences TTVR...

Breaking barriers in tricuspid valve repair

Early diagnosis and lifetime management of valvular heart disease: new tools and treatment paradigms

25 Nov 2024 – From PCR London Valves 2024

What if we could detect and treat progressive heart valve disease before it worsens? Dives into the latest breakthroughs with this video, showcasing how emerging technologies and innovative strategies are transforming patient outcomes.

Gain insights from the RECOVERY, AVATAR, EVOLVED and EARLY TAVR trials, and discover how AI,...

Early diagnosis and lifetime management of valvular heart disease: new tools and treatment paradigms

Meet the masters: M-TEER

24 Nov 2024 – From PCR London Valves 2024

Curious about the key strategies for successful mitral TEER? Don’t miss this video where top experts in the field share their experiences and provide practical advice on tackling the procedure.

Get valuable insights into case selection, procedural strategies and complication management, and watch as experienced operators reveal...

Meet the masters: M-TEER

The top clinical cases in interventional cardiology

25 Nov 2024 – From PCR London Valves 2024

Curious about the latest in interventional cardiology? Don't miss this video!

You'll discover groundbreaking techniques for complex conditions, from treating mitral regurgitation after healed endocarditis to repairing the tricuspid valve in dextrocardia. You'll also see the latest advances (including the SAPIEN 3 Tendyne device) and gain expert...

The top clinical cases in interventional cardiology

Tricuspid TEER - Advanced skills

25 Nov 2024 – From PCR London Valves 2024

Want to take your tricuspid TEER skills to the next level? Watch this video!

You’ll discover how to tackle common anatomical challenges, improve your imaging techniques with tools like intra-cardiac echocardiography and learn expert strategies for managing complex cases. Don't miss these valuable tips and tricks!

Tricuspid TEER - Advanced skills

Parading progress in transcatheter valve interventions

25 Nov 2024 – From PCR London Valves 2024

Curious about the future of transcatheter valve interventions? Watch this video to get an exclusive preview of groundbreaking (pre-CE mark) technologies shaping the future of valve repair!

You’ll discover the latest innovations in structural intervention devices, including next-gen technologies like the Mitral Butterfly, Vesalius, MonarQ and Luna...

Parading the progress in transcatheter valve interventions

PCR Valves e-Course: Sponsored Programme

Prepare to ask questions and comments in the chat box during each sponsored session, and access Expert Interviews on key topics 24/7!
PCR Valves e-Course: Sponsored Programme

EuroIntervention: Meet Cory, your new AI Assistant!

26 Mar 2024

Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.

Introducing Cory, EuroIntervention's multilingual new AI assistant!

All-new EuroPCR 2021: what’s on?

Watch an interview with the Course Directors to discover all about the 4 live channels, 5 TV studios, 10 PCR Hubs worldwide and what’s on before, during and after EuroPCR!
EuroPCR 2021: what's on

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

M. Pighi

Author

Michele Pighi
Bioprosthetic valve fracture in ViV-TAVR

MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.

15 May 2024

EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

15 May 2024

Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF

When transfemoral TAVI is not an option: rethinking alternative access strategies

18 Jun 2026

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author

Ulrich Schaefer
Alternative access, if transfemoral is not working

ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention

29 Aug 2023

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Claudio Laudani

Author

Claudio Laudani
Daniele Giacoppo

Author

Daniele Giacoppo
ILUMIEN IV: OCT versus angiography
Didn’t find what you were looking for?